Vanderbilt Institute of Chemical Biology Archive — Page 1 of 3
-
November 3, 2016
Brown named interim director of Institute of Chemical Biology
H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB). -
August 11, 2016
Transcription factor evolution
Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. -
April 20, 2016
How strep grabs on to platelets
New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections. -
April 7, 2016
Purdue’s Low set for next Flexner Discovery Lecture
Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14. -
January 28, 2016
Nobel laureate’s lecture highlights impact of science
“Stay with science,” Nobel laureate Peter Agre, M.D., advised dozens of medical and graduate students who attended his lecture at Vanderbilt University Medical Center last week. “It will take you to fascinating places.” -
October 2, 2015
The yin and yang of COX-2
New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs. -
June 17, 2015
Lit up COX-2 cancer probe
A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer.